Beyond structure, to survival: Activation of Stat3 by cadherin engagement

Biochemistry and Cell Biology

Volumn 87, Issue 6, 2009, Pages 835-843

  Raptis, Leda ^a   Arulanandam, Rozanne ^a   Vultur, Adina ^a   Geletu, Mulu ^a   Chevalier, Sébastien ^b   Feracci, Hélène ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cell survival; E cadherin; Racl Cdc42; Signal transduction; Stat3

Indexed keywords

ACTIVITY LEVELS; CELL DENSITY; CELL POLARITY; CELL SURVIVAL; CELLULAR PROCESS; DENSITY-DEPENDENT; E-CADHERIN; E-CADHERINS; EXTRACELLULAR SIGNAL-REGULATED KINASE; GROWTH FACTOR; GROWTH OF CELLS; NORMAL TISSUE; SIGNAL TRANSDUCERS;

ADHESION; AGGLOMERATION; BACTERIOPHAGES; CELL ADHESION; CHEMICAL ACTIVATION; ENZYME ACTIVITY; ONCOGENIC VIRUSES; TRANSDUCERS;

SIGNAL TRANSDUCTION;

CADHERIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN CDC42; RAC1 PROTEIN; STAT3 PROTEIN;

CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL POLARITY; EPITHELIUM CELL; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CADHERINS; CELL LINE; CELL SURVIVAL; INTERLEUKIN-6; JANUS KINASE 1; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 74549145229     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O09-061     Document Type: Short Survey

References (73)

1. Alattia, JR., Ames, J.B., Porumb, T., Tong, K.I., Heng, Y.M., Ottensmeyer, P., et al. 1997. Lateral self-assembly of E-cadherin directed by cooperative calcium binding. FEBS Lett. 417(3): 405-408. doi:10.1016/50014-5793(97)01333-1. PMID:9409761.
2. Amin, H.M., McDonnell, T.J., Ma, Y., Lin, Q., Fujio, Y., Kunisada, K., et al. 2004. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene, 23(32): 5426-5434. doi:10.1038/sj.onc.1207703. PMID:15184887.
3. Anagnostopoulou, A., Vultur, A., Arulanandam, R., Cao, J., Turkson, J., Jove, R., et al. 2006. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Cancer Lett. 242(1): 120-132. doi:10.1016/j.canlet.2005.10.047. PMID:16377083.
4. Arulanandam, R., Vultur, A., Cao, J., Carefoot, E., Elliott, B.E., Truesdell, P.F., et al. 2009. Cadherin-cadherin engagement promotes cell survival via Rac1/Cdc42 and signal transducer and activator of transcription-3. Mol. Cancer Res. 7(8): 1310-1327. doi:10.1158/1541-7786.MCR-08-0469. PMID:19671682.
5. Bayas, M.V., Leung, A., Evans, E., and Leckband, D. 2006. Life-time measurements reveal kinetic differences between homophilic cadherin bonds. Biophys. J. 90(4): 1385-1395. doi:10.1529/biophysj.105.069583. PMID:16326909.
6. Benjamin, J.M., and Nelson, W.J. 2008. Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis. Semin. Cancer Biol. 18(1): 53-64. doi:10.1016/j.semcancer.2007.08.003. PMID:17945508.
7. Berishaj, M., Gao, S.P., Ahmed, S., Leslie, K., Al-Ahmadie, H., Gerald, W.L., et al. 2007. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res. 9(3): R32. doi:10.1186/bcr1680. PMID:17531096.
8. Boggon, T.J., Murray, J., Chappuis-Flament, S., Wong, E., Gumbiner, B.M., and Shapiro, L. 2002. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science, 296(5571): 1308-1313. doi:10.1126/science. 1071559. PMID:11964443.
9. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., et al. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10(1): 105-115. doi:10.1016/51074-7613(00)80011-4. PMID:10023775.
10. Cereijido, M., Robbins, E.S., Dolan, W.J., Rotunno, C.A., and Sabatini, D.D. 1978. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J. Cell Biol. 77(3): 853-880. doi:10.1083/jcb.77.3. 853. PMID:567227.
11. Chen, C.P., Posy, S., Ben-Shaul, A., Shapiro, L., and Honig, B.H. 2005. Specificity of cell-cell adhesion by classical cadherins: Critical role for low-affinity dimerization through beta-strand swapping. Proc. Natl. Acad. Sci. U.S.A. 102(24): 8531-8536. doi:10.1073/pnas.0503319102. PMID:15937105.
12. Chen, Q., Watson, J.T., Marengo, S.R., Decker, K.S., Coleman, I., Nelson, P.S., and Sikes, R.A. 2006. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo. Cancer Lett. 244(2): 274-288. doi:10.1016/j.canlet.2005.12.027. PMID: 16500022.
13. Cobleigh, M.A., Vogel, C.L., Tripathy, D., Robert, N.J., Scholl, S., Fehrenbacher, L., et al. 1999. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17(9): 2639-2648. PMID:10561337.
14. Courjean, O., Chevreux, G., Perret, E., Morel, A., Sanglier, S., Potier, N., et al. 2008. Modulation of E-cadherin monomer folding by cooperative binding of calcium ions. Biochemistry, 47(8): 2339-2349. doi:10.1021/bi701340d. PMID:18232713.
15. Debidda, M., Wang, L., Zang, H., Poli, V., and Zheng, Y. 2005. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 280(17): 17275-17285. doi:10.1074/ jbc.M413187200. PMID:15705584.
16. du Roure, O., Buguin, A., Feracci, H., and Silberzan, P. 2006. Homophilic interactions between cadherin fragments at the single molecule level: an AFM study. Langmuir, 22(10): 4680- 4684. doi:10.1021/1a0531852. PMID:16649782.
17. Etienne-Manneville, S., and Hall, A. 2002. Rho GTPases in cell biology. Nature, 420(6916): 629-635. doi:10.1038/nature01148. PMID:12478284.
18. Faruqi, T.R., Gomez, D., Bustelo, X.R., Bar-Sagi, D., and Reich, N.C. 2001. Rac1 mediates STAT3 activation by autocrine IL-6. Proc. Natl. Acad. Sci. U.S.A. 98(16): 9014-9019. doi:10.1073/pnas.161281298. PMID:11470914.
19. Fischer, P., and Hilfiker-Kleiner, D. 2008. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br. J. Pharmacol. 153(Suppl 1): S414-S427. doi:10.1038/bjp.2008. 1. PMID:18246092.
20. Frank, D.A. 2007. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 251(2): 199-210. doi:10.1016/j.canlet.2006. 10.017. PMID:17129668.
21. Fukuyama, T., Ogita, H., Kawakatsu, T., Inagaki, M., and Takai, Y. 2006. Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway. Oncogene, 25(1): 8-19. PMID:16170364.
22. Geletu, M., Chaize, C., Arulanandam, R., Vultur, A., Kowolik, C., Anagnostopoulou, A., et al. 2009. Stat3 activity is required for gap junctional permeability in normal epithelial cells and fibroblasts. DNA Cell Biol. 28: 319-327.
23. Germain, D., and Frank, D.A. 2007. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin. Cancer Res. 13(19): 5665-5669. doi:10.1158/1078-0432.CCR- 06-2491. PMID:17908954.
24. Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., et al. 2006. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res. 12(1): 11-19. doi:10.1158/1078-0432.CCR-04-1752. PMID:16397018.
25. Gumbiner, B.M. 2000. Regulation of cadherin adhesive activity. J. Cell Biol. 148(3): 399-404. doi:10.1083/jcb.148.3.399. PMID: 10662767.
26. Harries, M., and Smith, I. 2002. The development and clinical use of trastuzumab (Herceptin). Endocr. Relat. Cancer, 9(2): 75-85. doi:10.1677/erc.0.0090075. PMID:12121832.
27. Häussinger, D., Ahrens, T., Aberle, T., Engel, J., Stetefeld, J., and Grzesiek, S. 2004. Proteolytic E-cadherin activation followed by solution NMR and X-ray crystallography. EMBO J. 23(8): 1699-1708. doi:10.1038/sj.emboj.7600192. PMID:15071499.
28. Hulpiau, P., and van Roy, F. 2009. Molecular evolution of the cadherin superfamily. Int. J. Biochem. Cell Biol. 41(2): 349-369. doi:10.1016/j.biocel.2008.09.027. PMID:18848899.
29. Hung, W., and Elliott, B. 2001. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. J. Biol. Chem. 276(15): 12395-12403. doi:10.1074/jbc.M010715200. PMID: 11278729.
30. Hynes, N.E., and Lane, HA. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer, 5(5): 341- 354. doi:10.1038/nrc1609. PMID:15864276.
31. Kim, S.H., Li, Z., and Sacks, D.B. 2000. E-cadherin-mediated cell-cell attachment activates Cdc42. J. Biol. Chem. 275(47): 36999-37005. doi:10.1074/jbc.M003430200. PMID:10950951.
32. Koch, A.W., Pokutta, S., Lustig, A., and Engel, J. 1997. Calcium binding and homoassociation of E-cadherin domains. Biochemistry, 36(25): 7697-7705. doi:10.1021/bi9705624. PMID: 9201910.
33. Kortylewski, M., Heinrich, P.C., Mackiewicz, A., Schniertshauer, U., Klingmüller, U., Nakajima, K., et al. 1999. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene, 18(25): 3742-3753. doi:10.1038/sj.onc.1202708. PMID:10391682.
34. Kreis, S., Munz, G.A., Haan, S., Heinrich, P.C., and Behrmann, I. 2007. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases. Mol. Cancer Res. 5(12): 1331-1341. doi:10.1158/1541-7786.MCR-07- 0317. PMID:18171991.
35. Larue, L., Antos, C., Butz, S., Huber, O., Delmas, V., Dominis, M., and Kemler, R. 1996. A role for cadherins in tissue formation. Development, 122(10): 3185-3194. PMID:8898231.
36. Lázár-Molnár, E., Hegyesi, H., Tóth, S., and Falus, A. 2000. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12(6): 547-554. doi:10.1006/cyto.1999. 0614. PMID:10843728.
37. Lou, W., Ni, Z., Dyer, K., Tweardy, D.J., and Gao, A.C. 2000. Interleukin-6 induces prostate cancer cell growth accompanied by activation of star signaling pathway. Prostate, 42(3): 239-242. doi: 10. 1002/(SICI)1097-0045(20000215)42:3〈239:AID-PROS10〉3.0.CO;2-G. PMID:10639195.
38. Lu, C., Sheehan, C., Rak, J.W., Chambers, C.A., Hozumi, N., and Kerbel, R.S. 1996. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells. Clin. Cancer Res. 2(8): 1417-1425. PMID:9816316.
39. Lynch, E.A., Stall, J., Schmidt, G., Chavrier, P., and D'Souza-Schorey, C. 2006. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol. Biol. Cell, 17(5): 2236-2242. doi:10.1091/mbc.E05-08- 0779. PMID:16481404.
40. Makagiansar, I.T., Avery, M., Hu, Y., Audus, K.L., and Siahaan, T.J. 2001. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Pharm. Res. 18(4): 446-453. doi:10.1023/A:1011094025008. PMID:11451030.
41. Misfeldt, D.S., Hamamoto, S.T., and Pitelka, D.R. 1976. Transepithelial transport in cell culture. Proc. Natl. Acad. Sci. U.S.A. 73(4): 1212-1216. doi:10.1073/pnas.73.4.1212. PMID: 1063404.
42. Nakagawa, M., Fukata, M., Yamaga, M., Itoh, N., and Kaibuchi, K. 2001. Recruitment and activation of Racl by the formation of E-cadherin-mediated cell-cell adhesion sites. J. Cell Sci. 114(Pt 10): 1829-1838. PMID:11329369.
43. Nakamura, T., Kato, Y., Fuji, H., Horiuchi, T., Chiba, Y., and Tanaka, K. 2003. E-cadherin-dependent intercellular adhesion enhances chemoresistance. Int. J. Mol. Med. 12(5): 693-700. PMID:14532995.
44. Niu, G., Wright, K.L., Huang, M., Song, L., Haura, E., Turkson, J., et al. 2002a. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene, 21(13): 2000-2008. doi:10.1038/sj.onc. 1205260. PMID:11960372.
45. Niu, U., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., et al. 2002b. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene, 21(46): 7001-7010. doi:10.1038/sj.onc.1205859. PMID:12370822.
46. Niu, G., Wright, K.L., Ma, Y., Wright, G.M., Huang, M., Irby, R., et al. 2005. Role of Stat3 in regulating p53 expression and function. Mol. Cell. Biol. 25(17): 7432-7440. doi:10.1128/MCB.25.17.7432-7440.2005. PMID:16107692.
47. Noren, N.K., Niessen, C.M., Gumbiner, B.M., and Burridge, K. 2001. Cadherin engagement regulates Rho family GTPases. J. Biol. Chem. 276(36): 33305-33308. doi:10.1074/jbc.C100306200. PMID:11457821.
48. Nose, A., Nagafuchi, A., and Takeichi, M. 1988. Expressed recombinant cadherins mediate cell sorting in model systems. Cell, 54(7): 993-1001. doi: 10.1016/0092-8674(88)90114-6. PMID:3416359.
49. Onishi, A., Chen, Q., Humtsoe, JO., and Kramer, RH. 2008. STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells. Exp. Cell Res. 314(2): 377-386. doi:10.1016/j.yexcr.2007.09.018. PMID:17961551.
50. Parisini, E., Higgins, J.M., Liu, J.H., Brenner, M.B., and Wang, J.H. 2007. The crystal structure of human E-cadherin domains 1 and 2, and comparison with other cadherins in the context of adhesion mechanism. J. Mol. Biol. 373(2): 401-411. doi:10.1016/j. jmb.2007.08.011. PMID:17850815.
51. Patel, S.D., Ciatto, C., Chen, C.P., Bahna, F., Rajebhosale, M., Arkus, N., et al. 2006. Type II cadherin ectodomain structures: implications for classical cadherin specificity. Cell, 124(6): 1255-1268. doi:10.1016/j.cell.2005.12.046. PMID:16564015.
52. Perret, E., Benuliel, A.M., Nassoy, P., Pierres, A., Delmas, V., Thiery, J.P., et al. 2002. Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis. EMBO J. 21(11): 2537-2546. doi:10.1093/emboj/21.11.2537. PMID:12032067.
53. Perret, E., Leung, A., Feracci, H., and Evans, E. 2004. Transbonded pairs of E-cadherin exhibit a remarkable hierarchy of mechanical strengths. Proc. Natl. Acad. Sci. U.S.A. 101(47): 16472-16477. doi:10.1073/pnas. 0402085101. PMID:15546992.
54. Pierres, A., Prakasam, A., Touchard, D., Benoliel, A.M., Bongrand, P., and Leckband, D. 2007. Dissecting subsecond cadherin bound states reveals an efficient way for cells to achieve ultra- fast probing of their environment. FEBS Lett. 581(9): 1841-1846. doi:10.1016/j.febslet.2007.03.077. PMID:17434495.
55. Pokutta, S., Herrenknecht, K., Kemler, R., and Engel, J. 1994. Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. Eur. J. Biochem. 223(3): 1019-1026. doi:10.1111/j.1432-1033.1994.tb19080.x. PMID: 8055942.
56. Schick, N., Oakeley, E.J., Hynes, N.E., and Badache, A. 2004. TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity. J. Biol. Chem. 279(37): 38787-38796. doi:10.1074/jbc.M312581200. PMID:15229229.
57. Shlyonsky, V., Goolaerts, A., Van Beneden, R., and Sariban-Sohraby, S. 2005. Differentiation of epithelial Na+ channel function. An in vitro model. J. Biol. Chem. 280(25): 24181-24187. doi:10.1074/jbc.M413823200. PMID:15817472.
58. Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W.J., and Jove, R. 2000. Induction of p21WAF1/CIP1 and cydin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene, 19(48): 5419-5427. doi: 10.1038/sj.onc.1203947. PMID: 11114718.
59. Sriuranpong, V., Park, J.I., Amornphimoltham, P., Patel, V., Nelkin, B.D., and Gutkind, J.S. 2003. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 63(11): 2948-2956. PMID:12782602.
60. Steinman, R.A., Wentzel, A., Lu, Y., Stehle, C., and Grandis, J.R. 2003. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2. Oncogene, 22(23): 3608-3615. doi:10.10381sj.onc.1206523. PMID:12789269.
61. Su, H.W., Yeh, H.H., Wang, S.W., Shen, M.R., Chen, T.L., Kiela, P.R., et al. 2007. Cell confluence-induced activation of signal transducer and activator of transcription-3 (Stat3) triggers epithelial dome formation via augmentation of sodium hydrogen exchanger-3 (NHE3) expression. J. Biol. Chem. 282(13): 9883-9894. doi:10.1074/jbc.M606754200. PMID:17276988.
62. Su, H.W., Wang, S.W., Ghishan, F.K., Kiela, P.R., and Tang, M.J. 2009. Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation. Am. J. Physiol. Cell Physiol. 296(1): C13-C24. doi:10.1152/ajpcell.00263.2008. PMID:19064501.
63. Takeichi, M. 1995. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7(5): 619-627. doi:10.1016/0955-0674(95)80102-2. PMID:8573335.
64. Turkson, J., Kim, J.S., Zhang, S., Yuan, J., Huang, M., Glenn, M., et al. 2004a. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3(3): 261-269. PMID:15026546.
65. Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanico, J., Mora, LB., et al. 2004b. Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol. Cancer Ther. 3(12): 1533-1542. PMID: 15634646.
66. Valentich, J.D., Tchao, R., and Leighton, J. 1979. Hemicyst formation stimulated by cyclic AMP in dog kidney cell line MDCK. J. Cell. Physiol. 100(2): 291-304. doi:10.1002/jcp.1041000210. PMID:229113.
67. Vogel, C.L., Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., et al. 2002. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-over-expressing metastatic breast cancer. J. Clin. Oncol. 20(3): 719-726. doi:10.1200/JCO.20.3.719. PMID:11821453.
68. Vultur, A., Cao, J., Arulanandam, R., Turkson, J., Jove, R., Greer, P., et al. 2004. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene, 23(15): 2600-2616. doi:10.1038/sj.onc. 1207378. PMID:15007380.
69. Vultur, A., Arulanandam, R., Turkson, J., Niu, G., Jove, R., and Raptis, L. 2005. Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Mol. Biol. Cell, 16(8): 3832-3846. doi:10.1091/mbc.E04-12-1104. PMID:15917293.
70. Yang, J., and Stark, G.R. 2008. Roles of unphosphorylated STATs in signaling. Cell Res. 18(4): 443-451. doi:10.1038/cr.2008.41. PMID:18364677.
71. Yu, H., and Jove, R. 2004. The STATs of cancer - new molecular targets come of age. Nat. Rev. Cancer, 4(2): 97-105. doi:10.1038/nrc1275. PMID:14964307.
72. Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., et al. 2000. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem. 275(32): 24935-24944. doi:10.1074/jbc.M002383200. PMID:10823829.
73. Zhang, F., Li, C., Halfter, H., and Liu, J. 2003. Delineating an on-costatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and cxtracellular matrix deposition of MCF-7 cells. Oncogene, 22(6): 894-905. doi:10.1038/sj.onc.1206158. PMID:12584569.